National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort
NORTHAMPTON, MA / ACCESS Newswire / September 9, 2026 / Organizations Across Sectors Unite Through the Winn Awards to Advance Better Science For All Previously published by the Robert A. Winn Excellence in Clinical Trials Award ProgramA growing …
NORTHAMPTON, MA / ACCESS Newswire / September 9, 2026 / Organizations Across Sectors Unite Through the Winn Awards to Advance Better Science For All
Previously published by the Robert A. Winn Excellence in Clinical Trials Award Program
A growing coalition of pharmaceutical companies, nonprofit organizations, academic institutions, and clinical research leaders came together through the Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards) to train a new generation of physicians to solve one of healthcare's most urgent challenges: improving representation in clinical trials and ensuring all communities have access to the latest advances in medicine.
As 80 talented medical students from across the country participated in the fifth annual cohort of the Winn Awards' signature Clinical Investigator Pathway Program (Winn CIPP) at 18 top research institutions, leaders across sectors are reaffirming a shared commitment to ensuring that clinical trials better reflect and serve the populations most affected by disease.
The Winn Awards is a national initiative focused on preparing physicians and researchers to design and conduct clinical trials with a strong emphasis on community engagement, trust-building, and improving participation in research. Through immersive education, mentorship, and hands-on clinical research experiences, the program equips trainees with the tools needed to help advance more effective and accessible healthcare for all communities. The Winn CIPP accomplishes this by teaching medical students about the importance of offering clinical trials, exposing them to community-centered research, and helping them understand the pathways to becoming a physician-scientist who works on clinical trials.
What makes the initiative unique is not only its mission, but also the breadth of organizations working together toward this shared goal.
Established by the Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization, in 2020, the Winn Awards are supported by a growing coalition of funding partners and collaborators committed to strengthening the future clinical research workforce and improving participation in clinical trials. Funders supporting the 2026 Winn CIPP cohort include the Bristol Myers Squibb Foundation, Gilead Sciences, Amgen, Genentech, and AstraZeneca. These organizations join academic institutions, research centers, mentors, and nonprofit collaborators nationwide in supporting a growing movement to strengthen the future clinical research workforce.

